logo

Arrowhead Pharmaceuticals Inc. (ARWR)



Trade ARWR now with
  Date
  Headline
3/12/2018 7:30:57 AM Arrowhead Commences Dosing In Phase 1 Study Of ARO-AAT For Treatment Of Alpha-1 Liver Disease
2/22/2018 7:43:54 AM Arrowhead Gets Regulatory Clearance To Begin Phase 1 Study Of ARO-AAT For Treatment Of Alpha-1 Liver Disease
2/15/2018 7:31:39 AM Arrowhead Receives Regulatory Clearance To Begin Phase 1/2 Study Of ARO-HBV For Hepatitis B
2/9/2018 4:03:06 PM Arrowhead Pharma Q1 Loss/share $0.18 Vs. Loss $0.17 Year Ago
1/18/2018 9:10:47 AM Arrowhead Prices Public Offering Of 10 Mln Shares At $5.25 Per Share
1/5/2018 1:21:34 PM B. Riley FBR Starts Arrowhead Pharmaceuticals Inc. (ARWR) At Buy With $3.00 Price Target
9/18/2017 10:38:21 AM William Blair Upgrades Arrowhead Pharmaceuticals Inc. (ARWR) To Outperform From Market Perform
11/30/2016 6:08:08 AM Jefferies Is Increasing Arrowhead Pharmaceuticals Inc. (ARWR) FY 18 Estimate To -0.56 From -1.18
11/30/2016 6:07:57 AM Jefferies Is Increasing Arrowhead Pharmaceuticals Inc. (ARWR) FY 17 Estimate To -0.26 From -0.96
11/30/2016 6:07:44 AM Jefferies Is Increasing Arrowhead Pharmaceuticals Inc. (ARWR) Q4 17 Estimate To -0.13 From -0.42
11/30/2016 6:07:20 AM Jefferies Is Raising Arrowhead Pharmaceuticals Inc. (ARWR) Q3 17 Estimate To -0.15 From -0.38
11/30/2016 6:07:08 AM Jefferies Is Increasing Arrowhead Pharmaceuticals Inc. (ARWR) Q2 17 Estimate To -0.20 From -0.34
11/30/2016 6:06:53 AM Jefferies Is Increasing Arrowhead Pharmaceuticals Inc. (ARWR) Q1 17 Estimate To 0.22 From 0.18
8/10/2016 8:30:49 AM RBC Capital Markets Is Increasing Arrowhead Research Corp. (ARWR) 2017 Estimate To -1.26 From -1.27
8/10/2016 8:30:22 AM RBC Capital Markets Is Raising Arrowhead Research Corp. (ARWR) 2016 Estimate To -1.30 From -1.33
5/11/2016 7:56:29 AM RBC Capital Markets Is Raising Arrowhead Research Corp. (ARWR) 2017 Estimate To -1.27 From -1.38
  
 
>